The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 1.69%. However, over the last six months, the performance has been weaker by 42.39%. The price of PRAX increased 7.19% over the last 30 days. And in the last five days, it has surged by 22.24%.
Praxis Precision Medicines Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $86.93 on 11/12/24, while the lowest price for the same duration was marked at $33.01 on 06/20/24.
52-week price history of PRAX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Praxis Precision Medicines Inc’s current trading price is -9.97% away from its 52-week high, while its distance from the 52-week low is 137.08%. The stock’s price range during this period has varied between$33.01 and $86.93. The Praxis Precision Medicines Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.51 million for the day, a figure considerably higher than their average daily volume of 0.33 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Praxis Precision Medicines Inc (PRAX) has experienced a quarterly rise of 4.46% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.46B and boasts a workforce of 82 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 68.84, with a change in price of +26.23. Similarly, Praxis Precision Medicines Inc recorded 316,973 in trading volume during the last 100 days, posting a change of +50.41%.
PRAX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRAX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PRAX Stock Stochastic Average
Praxis Precision Medicines Inc’s raw stochastic average for the past 50 days is presently 69.14%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 85.32%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 61.18% and 52.33%, respectively.
